Mark J. Ratain to Triazines
This is a "connection" page, showing publications Mark J. Ratain has written about Triazines.
Connection Strength
0.211
-
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. Eur J Cancer. 2019 10; 120:132-139.
Score: 0.171
-
Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer. Cancer Med. 2018 11; 7(11):5478-5487.
Score: 0.040